Peter Stopfer
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
- Oncology 33
- Drug Transport and Resistance Mechanisms 12
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 5
-
- Lung Cancer Treatments and Mutations 15
- Co-authors
- Thomas Ebner (9 shared papers)Sven Wind (8 shared papers)R. Kaiser (18 shared papers)Kristell Marzin (5 shared papers)Matthias Freiwald (4 shared papers)Dietmar Ganßer (7 shared papers)Martina Uttenreuther‐Fischer (10 shared papers)Daniela N. Männel (5 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Clinical Pharmacokinetics (5 papers)Annals of Oncology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Peter Stopfer
70 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 93
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.2k
- Pharmacology 163
- Hepatology 103
- Cancer Research 172
Countries citing papers authored by Peter Stopfer
This map shows the geographic impact of Peter Stopfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stopfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stopfer more than expected).
Fields of papers citing papers by Peter Stopfer
This network shows the impact of papers produced by Peter Stopfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stopfer. The network helps show where Peter Stopfer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Stopfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 306 | |
| 2 | 2007 | 210 | |
| 3 | 2016 | 154 | |
| 4 | 2019 | 147 | |
| 5 | 2009 | 146 | |
| 6 | 2011 | 126 | |
| 7 | 2011 | 116 | |
| 8 | 2010 | 86 | |
| 9 | 2013 | 78 | |
| 10 | 2011 | 70 | |
| 11 | 2012 | 66 | |
| 12 | 2016 | 65 | |
| 13 | 2004 | 58 | |
| 14 | 2014 | 55 | |
| 15 | 2009 | 54 | |
| 16 | 2004 | 53 | |
| 17 | 2006 | 48 | |
| 18 | 2016 | 47 | |
| 19 | Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis. | 2002 | 47 |
| 20 | 2020 | 45 |
About Peter Stopfer
Peter Stopfer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pharmacology, having authored 71 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Drug Transport and Resistance Mechanisms (12 papers), HER2/EGFR in Cancer Research (12 papers), Pharmacogenetics and Drug Metabolism (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer Treatment and Pharmacology (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.2k citations), Pharmacology (163 citations), Hepatology (103 citations) and Cancer Research (172 citations). Peter Stopfer has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Thomas Ebner, Sven Wind, R. Kaiser, Kristell Marzin, Matthias Freiwald, Dietmar Ganßer, Martina Uttenreuther‐Fischer, Daniela N. Männel, Mehdi Shahidi and Thomas Hehlgans. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacokinetics, Annals of Oncology, Clinical Pharmacology & Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.